Eugene Schneider, EVP, Chf Clinical Develop Ofcr at IONIS PHARMACEUTICALS INC (IONS), sold 9,302 shares at $75.59 ($703K) on 2026-01-16, disclosed to the SEC on 2026-01-20.
Seasonal sale ($703k) by EVP, Chf Clinical Develop Ofcr — this insider has traded IONS in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| IONS | SELL | 2026-02-02 | $516K | — | Filing → |
| IONS | SELL | 2025-09-04 | $2.4M | — | Filing → |
| IONS | SELL | 2025-08-05 | $817K | — | Filing → |